Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications

BACKGROUND: Treatment of schizophrenia and major depressive disorder (MDD) with atypical antipsychotics (AAPs) show improved efficacy and reduced side effect burden compared with older antipsychotic medications. However, a risk of treatment-emergent adverse events (TEAEs) remains. TEAEs are hard to...

Descripción completa

Detalles Bibliográficos
Autores principales: Llorca, Pierre-Michel, Lançon, Christophe, Hartry, Ann, Brown, T. Michelle, DiBenedetti, Dana B., Kamat, Siddhesh A., François, Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307846/
https://www.ncbi.nlm.nih.gov/pubmed/28193195
http://dx.doi.org/10.1186/s12888-017-1213-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307846/
https://www.ncbi.nlm.nih.gov/pubmed/28193195
http://dx.doi.org/10.1186/s12888-017-1213-6

Ejemplares similares